Dean, Reginald L.

Opiate Receptors and Antagonists

Dean, Reginald L. - Opiate Receptors and Antagonists, ebook


Ebook, PDF with Adobe DRM
ISBN: 9781597451970
DRM Restrictions

PrintingNot allowed
Copy to clipboardNot allowed

Table of contents

I. Opioid Receptors

1. Ultra-Low-Dose Opioid Antagonists Enhance Opioid Analgesia and Reduce Tolerance
Lindsay H. Burns, Todd W. Vanderah, Hoau-Yan Wang

2. Upregulation of Opioid Receptors
Ellen M. Unterwald, Richard D. Howells

3. Imaging Human Brain Opioid Receptors: Applications to Substance Use Disorders
Mark K. Greenwald, Caren L. Steinmiller

4. Opioid Receptor Antagonist-Mediated Signaling in the Immune System
Jonathan Moorman, Zhi Qiang Yao, Edward J. Bilsky, Deling Yin

II. Opioid Antagonists: Chemistry and Pharmacology

5. The Chemistry and Pharmacology of ?-Opioid Antagonists
Jean M. Bidlack, Jennifer L. Mathews

6. Medicinal Chemistry of Kappa Opioid Receptor Antagonists
Cécile Béguin, Bruce M. Cohen

7. The Chemistry and Pharmacology of Delta Opioid Antagonists
Beatriz Fioravanti, Todd W. Vanderah

8. Novel Opioid Antagonists with Mixed/Dual Selectivity
Richard B. Rothman, Subramaniam Ananthan, Edward J. Bilsky

9. Experimental Utility and Clinical Potential of Irreversible Opioid Antagonists
Ellen A. Walker, Sandra D. Comer

10. Methylnaltrexone: A Peripherally Acting Opioid Antagonist
Chun-Su Yuan, Robert J. Israel

III. Substance Abuse

11. Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration
S. Stevens Negus

12. Naltrexone for Initiation and Maintenance of Opiate Abstinence
Kevin A. Sevarino, Thomas R. Kosten

13. Ultra-Low-Dose Naltrexone Decreases Dependence and Addictive Properties of Opioids
Lindsay H. Burns, Francesco Leri, Mary C. Olmstead

14. Can a Combination Formulation Containing a Neutral Opiate Antagonist Decrease the Abuse of ?-Agonist Opiates
John Mendelson, Mark Pletcher, Gantt Galloway

15. Effects of Opioid Antagonists on the Abuse-Related Effects of Psychomotor Stimulants and Nicotine
Brenda J. Gehrke, GehrkeToni S. Shippenberg

16. Potential Use of Opioid Antagonists in the Treatment of Marijuana Abuse and Dependence
B. Foll, Zuzana Justinova, G. Tanda, Marcello Solinas, Peter Selby, Steven R. Goldberg

17. Naltrexone in Smoking Cessation: A Review of the Literature and Future Directions
Andrea King, Rachel Torello, Suchitra Krishnan-Sarin, Stephanie O'Malley

IV. Alcohol and Ingestive Behaviors

18. Opioid Antagonists and Ethanol's Ability to Reinforce Intake of Alcoholic Beverages: Preclinical Studies
Larry D. Reid

19. Clinical Use of Opioid Antagonists in the Treatment of Alcohol Dependence
Raymond F. Anton

20. Preclinical Effects of Opioid Antagonists on Feeding and Appetite
Richard J. Bodnar

21. CNS Opiate Systems and Eating Disorders
Elliot D. Luby, David Koval

V. Behavioral Disorders

22. Potential Utility of Kappa Ligands in the Treatment of Mood Disorders
William A. Carlezon, Bruce M. Cohen

23. Opioid Antagonists in the Treatment of Pathological Gambling and Kleptomania
Jon E. Grant

24. Efficacy of Opioid Antagonists in Attentuating Self-Injurious Behavior
Curt A. Sandman

25. Pharmacotherapeutic Effects of Opioid Antagonists in Alcohol-Abusing Patients with Schizophrenia
Ismene Petrakis

VI. Medical Indications

26. Current Issues in the Use of Opioid Antagonists (Naltrexone for Opiate Abuse: A Re-Educational Tool as Well as an Effective Drug)
Colin Brewer, Emmanuel Streel

27. Emergency Room Use of Opioid Antagonists in Drug Intoxication and Overdose
Simon F. J. Clarke, Rob Török, Paul I. Dargan, Alison L. Jones

28. Kappa-Opioid Antagonists as Pruritogenic Agents
Alan Cowan, Saadet Inan

29. Clinical Effect of Opioid Antagonists on Clinical Pruritus
Nora V. Bergasa

30. Effects of Opioid Antagonists on l-DOPA-Induced Dyskinesia in Parkinson's Disease
Susan H. Fox, Tom H. Johnston, Jonathan M. Brotchie

31. Endocrine Effects of Opioid Antagonists
Jack H. Mendelson, Nancy K. Mello

32. Opioid Antagonists in Traumatic Shock: Animal and Human Studies
Liangming Liu

33. The Efficacy of Opioid Antagonists Against Heatstroke-Induced Ischemia and Injury in Rats
Mao-Tsun Lin, Ching-Ping Chang, Sheng-Hsien Chen

34. A Review of the Opioid System in Cancer Patients and Preliminary Results of Opioid Antagonists in the Treatment of Human Neoplasms
Paolo Lissoni

35. Nonclinical Pharmacology of VIVITROL®: A Monthly Injectable Naltrexone for the Treatment of Alcohol Dependence
Reginald L. Dean

36. The Development of Sustained-Release Naltrexone and Clinical Use in Treating Opiate Dependence
Gary K. Hulse, Sandra D. Comer, Maria A. Sullivan

37. The Development of ProNeura Technology for the Treatment of Addictions
Lauren C. Costantini

38. Development of Opioid Transdermal Delivery Systems
Kalpana S. Paudel, Stan L. Banks, Paul K. Kiptoo, Dana C. Hammell, R. Reddy Pinninti, Caroline Strasinger, Audra L. Stinchcomb

39. Intranasal Naloxone for Treatment of Opioid Overdose
Anne-Maree Kelly, Debra Kerr, Dietze Paul

Keywords: Biomedicine, Pharmacology/Toxicology

Publication year
Contemporary Neuroscience
Page amount
780 pages
Medicine, Health Care, Mode

Similar titles